CRA provided analysis and expert testimony on behalf of a boutique healthcare technology company in a patent infringement case against the subsidiary of an industrial conglomerate. CRA determined total damages to be over $157 million which substantially exceeded the total revenues earned by the plaintiff throughout the life of its business. The jury agreed with our assessments and the court awarded judgment in favor of our client in excess of $164 million.
Were shareholders harmed by Senate Bill 21’s amendments to the Delaware General Corporation Law?
Delaware Governor Meyer signed into law Senate Bill 21 (SB21) in March 2025, updating Delaware’s corporate law, with some of the key provisions including safe...